Securities code: Shenzhen Neptunus Bioengineering Co.Ltd(000078) securities abbreviation: Shenzhen Neptunus Bioengineering Co.Ltd(000078) Announcement No.: 2022005 Shenzhen Neptunus Bioengineering Co.Ltd(000078)
Announcement on expiration of approval for non-public offering of shares
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
On March 11, 2021, Shenzhen Neptunus Bioengineering Co.Ltd(000078) (hereinafter referred to as “the company”) received the reply on approving Shenzhen Neptunus Bioengineering Co.Ltd(000078) non-public development of shares (zjxk [2021] No. 677, hereinafter referred to as “the reply”) issued by the China Securities Regulatory Commission (hereinafter referred to as “the CSRC”), which approved the company’s non-public offering of no more than 651041666 new shares, This reply is valid for 12 months from the date of approval of issuance (March 5, 2021).
After obtaining the approval, the company has been actively promoting the issuance of this non-public offering of shares. However, due to changes in the capital market environment, issuance timing and other reasons, the company fails to implement this non-public offering of shares within the validity period of the approval, and the approval expires automatically.
The expiration of the approval for this non-public offering will not have a significant impact on the company’s production and operation activities. Please pay attention to the investment risks.
It is hereby announced.
Shenzhen Neptunus Bioengineering Co.Ltd(000078) board of directors
March 3, 2002
